These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 17387610)

  • 1. Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects.
    Osadchii OE
    Heart Fail Rev; 2007 Mar; 12(1):66-86. PubMed ID: 17387610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal changes in myocardial adrenergic regulation with the progression to pump dysfunction after chronic beta-adrenoreceptor activation in rats.
    Osadchii OE; Woodiwiss AJ; Deftereos D; Norton GR
    Pflugers Arch; 2007 Nov; 455(2):251-60. PubMed ID: 17558518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CaMKII-mediated increased lusitropic responses to beta-adrenoreceptor stimulation in ANP-receptor deficient mice.
    Yurukova S; Kilić A; Völker K; Leineweber K; Dybkova N; Maier LS; Brodde OE; Kuhn M
    Cardiovasc Res; 2007 Mar; 73(4):678-88. PubMed ID: 17107670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic sympathetic activation promotes downregulation of β-adrenoceptor-mediated effects in the guinea pig heart independently of structural remodeling and systolic dysfunction.
    Soltysinska E; Thiele S; Olesen SP; Osadchii OE
    Pflugers Arch; 2011 Oct; 462(4):529-43. PubMed ID: 21811789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavior of Hypertrophied Right Ventricle during the Development of Left Ventricular Failure Due to Myocardial Infarction.
    Dhalla NS; Mota KO; de Vasconcelos CML; Adameova A
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contractile responses to selective phosphodiesterase inhibitors following chronic beta-adrenoreceptor activation.
    Osadchii OE; Woodiwiss AJ; Norton GR
    Pflugers Arch; 2006 May; 452(2):155-63. PubMed ID: 16369769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation.
    Osadchii OE; Norton GR; McKechnie R; Deftereos D; Woodiwiss AJ
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1898-905. PubMed ID: 17158652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
    Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure.
    Karam S; Margaria JP; Bourcier A; Mika D; Varin A; Bedioune I; Lindner M; Bouadjel K; Dessillons M; Gaudin F; Lefebvre F; Mateo P; Lechène P; Gomez S; Domergue V; Robert P; Coquard C; Algalarrondo V; Samuel JL; Michel JB; Charpentier F; Ghigo A; Hirsch E; Fischmeister R; Leroy J; Vandecasteele G
    Circulation; 2020 Jul; 142(2):161-174. PubMed ID: 32264695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial phosphodiesterases and regulation of cardiac contractility in health and cardiac disease.
    Osadchii OE
    Cardiovasc Drugs Ther; 2007 Jun; 21(3):171-94. PubMed ID: 17373584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyocyte PKA Ablation Enhances Basal Contractility While Eliminates Cardiac β-Adrenergic Response Without Adverse Effects on the Heart.
    Zhang Y; Wang WE; Zhang X; Li Y; Chen B; Liu C; Ai X; Zhang X; Tian Y; Zhang C; Tang M; Szeto C; Hua X; Xie M; Zeng C; Wu Y; Zhou L; Zhu W; Yu D; Houser SR; Chen X
    Circ Res; 2019 Jun; 124(12):1760-1777. PubMed ID: 30982412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced basal contractility but reduced excitation-contraction coupling efficiency and beta-adrenergic reserve of hearts with increased Cav1.2 activity.
    Tang M; Zhang X; Li Y; Guan Y; Ai X; Szeto C; Nakayama H; Zhang H; Ge S; Molkentin JD; Houser SR; Chen X
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H519-28. PubMed ID: 20543081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-Nitrosylation of Calcium-Handling Proteins in Cardiac Adrenergic Signaling and Hypertrophy.
    Irie T; Sips PY; Kai S; Kida K; Ikeda K; Hirai S; Moazzami K; Jiramongkolchai P; Bloch DB; Doulias PT; Armoundas AA; Kaneki M; Ischiropoulos H; Kranias E; Bloch KD; Stamler JS; Ichinose F
    Circ Res; 2015 Oct; 117(9):793-803. PubMed ID: 26259881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propofol attenuates beta-adrenoreceptor-mediated signal transduction via a protein kinase C-dependent pathway in cardiomyocytes.
    Kurokawa H; Murray PA; Damron DS
    Anesthesiology; 2002 Mar; 96(3):688-98. PubMed ID: 11873046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1).
    Rosenkranz S; Flesch M; Amann K; Haeuseler C; Kilter H; Seeland U; Schlüter KD; Böhm M
    Am J Physiol Heart Circ Physiol; 2002 Sep; 283(3):H1253-62. PubMed ID: 12181157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor β₁ oppositely regulates the hypertrophic and contractile response to β-adrenergic stimulation in the heart.
    Huntgeburth M; Tiemann K; Shahverdyan R; Schlüter KD; Schreckenberg R; Gross ML; Mödersheim S; Caglayan E; Müller-Ehmsen J; Ghanem A; Vantler M; Zimmermann WH; Böhm M; Rosenkranz S
    PLoS One; 2011; 6(11):e26628. PubMed ID: 22125598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy.
    El-Armouche A; Wittköpper K; Degenhardt F; Weinberger F; Didié M; Melnychenko I; Grimm M; Peeck M; Zimmermann WH; Unsöld B; Hasenfuss G; Dobrev D; Eschenhagen T
    Cardiovasc Res; 2008 Dec; 80(3):396-406. PubMed ID: 18689792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
    Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
    Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial beta-adrenergic receptor expression and signal transduction after chronic volume-overload hypertrophy and circulatory congestion.
    Hammond HK; Roth DA; Insel PA; Ford CE; White FC; Maisel AS; Ziegler MG; Bloor CM
    Circulation; 1992 Jan; 85(1):269-80. PubMed ID: 1309445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
    Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
    Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.